Advances and Challenges in Cardiovascular Gene Therapy

Area of Science:

• Cardiovascular Medicine
• Gene Therapy
• Translational Science

Background:

• Numerous cardiovascular gene therapy strategies have not met clinical trial expectations.
• Despite setbacks, extensive research provides a foundation for future cardiovascular therapies.
• The demand for novel cardiovascular treatment options remains high.

Purpose of the Study:

• To review the challenges and successes in cardiovascular gene therapy.
• To emphasize the importance of bidirectional translationality in advancing gene therapy from research to clinical application.
• To propose strategies for enhancing the success rate of cardiovascular gene therapy in clinical settings.

Main Methods:

• Review of existing literature on cardiovascular gene therapy clinical trials and preclinical research.
• Analysis of safety data from various viral vectors, transgenes, and delivery methods.
• Discussion of the translational process, including animal models, preclinical endpoints, patient recruitment, and clinical endpoints.

Main Results:

• The safety of gene therapy in cardiovascular applications has been demonstrated.
• Significant improvements are needed in preclinical models and endpoint selection.
• Enhanced patient recruitment and selection strategies are crucial for clinical success.

Conclusions:

• Cardiovascular gene therapy has established safety profiles but requires optimized translational processes.
• Improving preclinical research and clinical trial design is essential for future success.
• Optimizing bidirectional translationality is critical to realizing the clinical potential of cardiovascular gene therapy.